Key result
Aortic regurgitation after TAVI, primarily paravalvular leak, is associated with worse mid-term outcomes, highlighting the importance of currently available prevention and treatment measures.
This review describes currently available measures to prevent and treat significant aortic regurgitation after TAVI, which is associated with worse mid-term mortality.
Significant aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI) has been shown to be associated with worse mid-term outcome. The two-year follow-up results of the PARTNER US trial showed that not only ≥3/4 AR grade, but also grade 2 had a significant impact on mortality. Thus, prevention and treatment of significant AR after TAVI is of great importance. Usually, AR after TAVI consists mostly of paravalvular leak and significant central AR is uncommon. Here we describe measures to decrease the risk of AR after TAVI which are currently available.
No takes yet. Share an insight, caveat, or question.
Hayashida et al. (2012) conducted a review in Aortic regurgitation after transcatheter aortic valve implantation. Measures to decrease the risk of aortic regurgitation was evaluated. Aortic regurgitation after TAVI, primarily paravalvular leak, is associated with worse mid-term outcomes, highlighting the importance of currently available prevention and treatment measures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: